Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 28.30
-0.60 (-2.08%)
Jan 22, 2026, 1:20 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 5.78 billion as of January 21, 2026. Its market cap has increased by 47.83% in one year.
Market Cap
5.78B
Enterprise Value
5.03B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.30
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 5.78B, a decrease of -41.50%. That is a compound annual growth rate of -13.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.79B | 0.70% |
| Dec 31, 2025 | 5.75B | 44.11% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.72B |
| Bora Pharmaceuticals Co., LTD. | 64.74B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |